Zymeworks Inc. ( ZYME) - Stock Earnings
ZYME Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 6, 2026, midnight | — / — | — | — / — | — |
ZYME Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -19.6 million USD | 27.6 million USD |
| 2025Q4 | -41.2 million USD | 2.5 million USD |
| 2026Q1 | -44.2 million USD | 2.4 million USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
ZYME Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -118.7 million USD | 76.0 million USD |
| 2024 | -122.7 million USD | 76.3 million USD |
| 2025 | -81.1 million USD | 106.0 million USD |
| 2026 Est. | — | — |
ZYME
Price: $22.86
52 week price:
Earnings Per Share: -1.37 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: Canada
Volume: 105946
Ebitda: -15.5 millionMarket Capitalization: 1.9 billion